A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy

Autor: Lip, GY, Rasmussen, Lars Hvilsted, Olsson, SB, Zetterstrand, S, Stahre, C, Bylock, A, Aunes Jansson, M, Wåhlander, K

Publikováno v: Lip, GY, Rasmussen, L H, Olsson, SB, Zetterstrand, S, Stahre, C, Bylock, A, Aunes Jansson, M & Wåhlander, K 2009, ' A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy ', Circulation, no. 18 Suppl, pp. S1129 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::ad2b987ddc4fe7632dc28f28ff5f7c71
https://pure.au.dk/portal/da/publications/a-phase-2-feasibility-trial-of-the-oral-direct-thrombin-inhibitor-azd0837-in-the-prevention-of-stroke-and-systemic-embolic-events-in-patients-with-atrial-fibrillation-who-are-unable-to-unwilling-to-take-warfarin-therapy(9269df50-1ba5-11df-b95d-000ea68e967b).html

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and theHeart Rhythm Society

Autor: Fuster, V, Rydén, Le, Cannom, Ds, Crijns, Hj, Curtis, Ab, Ellenbogen, Ka, Halperin, Jl, Le Heuzey JY, Kay, Gn, Lowe, Je, Olsson, Sb, Prystowsky, En, Tamargo, Jl, Wann, S, Smith SC Jr, Jacobs, Ak, Adams, Cd, Anderson, Jl, Antman, Em, Hunt, Sa, Nishimura, R, Ornato, Jp, Page, Rl, Riegel, B, Priori, Sg, Blanc, Jj, Budaj, A, Camm, Aj, Dean, V, Deckers, Jw, Despres, C, Dickstein, K, Lekakis, J, Mcgregor, K, Metra, Marco, Morais, J, Osterspey, A, Zamorano, Jl, American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::65962b39a9bfa3fe8c22e7b3008bc3e8
http://hdl.handle.net/11379/22764

ACC/AHA/ESC 2006 Guidelines for the Managementof Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Autor: Fuster, V, Rydén, Le, Cannom, Ds, Crijns, Hj, Curtis, Ab, Ellenbogen, Ka, Halperin, Jl, Le Heuzey JY, Kay, Gn, Lowe, Je, Olsson, Sb, Prystowsky, En, Tamargo, Jl, Wann, S, Smith SC Jr, Jacobs, Ak, Adams, Cd, Anderson, Jl, Antman, Em, Hunt, Sa, Nishimura, R, Ornato, Jp, Page, Rl, Riegel, B, Priori, Sg, Blanc, Jj, Budaj, A, Camm, Aj, Dean, V, Deckers, Jw, Despres, C, Dickstein, K, Lekakis, J, Mcgregor, K, Metra, Marco, Morais, J, Osterspey, A, Zamorano, Jl, American College of Cardiology/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::ae69a8a17f8ed61de7755f2f60e85c0c
http://hdl.handle.net/11379/159555

Prophylactic treatment after electroconversion of atrial fibrillation

Autor: Björn W. Karlson, Johan Herlitz, Nils Edvardsson, Olsson Sb

Publikováno v: Clinical cardiology. 13(4)

Atrial fibrillation is a common arrhythmia. Sinus rhythm can often be restored by electroconversion, but the relapse rate is high. Various antiarrhythmic drugs have been used to maintain sinus rhythm after electroconversion. This article reviews the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e171a52c87ac432d80b31e14968b24
https://pubmed.ncbi.nlm.nih.gov/2190725

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.